You’re not alone if you’ve never heard of “Alternative Summary Reporting.” It’s been around for decades, and the FDA has decided to finally end what many considered to be a reckless, even dangerous practice that has allowed medical device manufacturers to hide malfunctions of their devices from the public. The FDA has specific requirements for … [Read more...]
Endo International Announces Plan to Resolve Remaining Mesh-Related Lawsuits
Endo International recently indicated that it would set aside $775 million to resolve thousands of remaining lawsuits regarding the faulty vaginal mesh devices sold by the company. The mesh devices have been linked to numerous accounts of related incontinence and pain, leading the company to cease all sales of the product last year. The $775 … [Read more...]
75 Transvaginal Mesh Lawsuits Settled
75 more transvaginal mesh lawsuits have reportedly been settled by C.R. Bard, Inc. The lawsuits were part of a federal multidistrict litigation that is underway in a federal court in West Virginia. The agreement for the settlement however remains confidential just as with the other previous settlements. Dangers of Transvaginal Mesh C.R. Bard, … [Read more...]
149 Transvaginal Mesh Cases Against C.R. Bard Dismissed – Already Settled
By Avon Alexander, Staff Writer Medical device manufacturer C.R. Bard was given a legal victory in court this week, after a U.S. District Court judge dismissed dozens of vaginal mesh product liability cases against the company. In all 149 cases against Bard were dismissed by U.S. District Court for Southern West Virginia Judge Joseph Goodwin, … [Read more...]
Boston Scientific Mesh Allegations Being Investigated by FDA
The Federal Drug Administration (FDA) is currently investigating Boston Scientific due to allegations that the manufacturer has used counterfeit raw material in their surgical mesh products. The mesh implants are used to treat urinary incontinence and a number of other organ problems in women. Thousands of women have already filed lawsuits … [Read more...]
Recent Comments